healthcare professional for medical advice
short term use of oral contraceptive
relative excess
edema
unusual spot
hepatocellular carcinoma in the united state
month
heaviness in the chest
tiredness
risk of gallbladder disease
cardiovascular
dark color urine
venous thromboembolism
pulmonary embolism
oral contraceptive
incidence of venous thrombosis in woman
cough of blood
recurrent abnormal vaginal bleeding
rash
favorable change in lipid profile
fluid retention
use of oral contraceptive combination
difficulty breathing
case of oral contraceptive
change in sexual interest
change in amount of urine
world health organization committee
spot
adverse lipid metabolism
progestin component of these formulation
association between oral contraceptive use
intrahepatic cholestasis
crush chest pain
woman
change in vaginal secretion
available oral contraceptive combination
hair loss
weakness
preexist
available preparation
nonhormonal cause of such bleeding
risk of ovarian cyst
vomit
develop country
manufacturer of oral contraceptive product
fatiguehair
gallbladder disease
arterial thrombosis
association
nausea
oral contraceptive use
association with oral contraceptive
wear contact lens
investigator
risk of epithelial ovarian cancer
yellow of the skin
hive
oily skinbreast tendernessdepressiontiredness
tenderness
benefit
myocardial infarction
dizziness
breast lump
cardiovascular system
miss menstrual period
tightness in the chest
breast cancer
ovarian cancer
glucose tolerance
public health importance in the united state
possible relationship between the use of oral contraceptive
altered carbohydrate metabolism
swell of the finger
incidence of iron deficiency anemia
decrease glucose tolerance
depression
vaginal irritation
inherit clotting defect
systemic lupus erythematosus
first several cycle of oral contraceptive use
older formulation
appetiteweight
hepatitis b virus infection
exogenous estrogen
protection against ovarian cancer
vascular thrombosis
risk of ectopic pregnancy
tenderness in the stomach
breast discharge
detailed information
mood change
lip
tolerance
large number of confounding factor
woman on oral contraceptive combination product
higher risk for endometrial carcinoma than other woman
estrogen component of oral contraceptive combination
esophageal ulceration
leg
neoplasm of the uterine cervix
confusion
increase ldl cholesterol level
breast tenderness
difficulty
change in vision
combine oral contraceptive on the risk of cervical adenocarcinoma
most woman
experienced oligomenorrhea
incidence of hospitalization for pelvic inflammatory disease
exist cancer
bleed
severe lipidemia
progestin in a
potent progestin
committee of the world health organization
liver cell adenoma
alteration in lipid profile
exogenous progestin
long term risk for mortality
experienced several noncontraceptive health benefit
antiestrogen
use of oral contraceptive
protection
smoke
epidermoid carcinoma
nauseaheadachemelasmahypertensionbreast tendernessedemaestrogen deficiency
tongue
leg pain
variation in the hormonal content of oral contraceptive
swell of the mouth
acne
cardiovascular risk factor
cholesterol level
overall association between oral contraceptive use
relative risk of hepatocellular carcinoma
malignant neoplasm
actual number of case of liver cancer in the united state
late breakthrough bleedingamenorrheahypermenorrheaestrogen
risk of thromboembolism
gaincholestatic jaundiceprogestin deficiency
nulliparous woman
dysmenorrhea
give product
risk
ethinyl estradiol
contraindication
conception delay
eye
bleedingincreased spottinghypomenorrhea
investigation into the epidemiology of this neoplasm
addition
observe association
faint
development of new case of cancer
pelvic inflammatory disease in woman
hepatocellular carcinoma
young woman
ankle
precipitation of panic disorder
one side weakness
underlie cardiovascular disease
rare case of oral contraceptive
calf
headache
risk of breast cancer
pelvic inflammatory disease
increase risk
case of fatal pulmonary venooclusive disease
mcg
differentiate hepatocellular carcinoma
deficiency of the estrogen
underlie
other western nation
other risk factor
possible relationship between oral contraceptive use
fda
change in weight
bloat
risk of ovarian cancer
develop change in contact lens tolerance
oral contraceptive combination
weak association between long term use of oral contraceptive
same committee
development of breast cancer
insufficient datum
strong association between oral contraceptive use
hepatic granuloma
hdl
complete loss of vision
stomach cramp
sudden severe headache
early midcycle breakthrough
stroke
light color bowel movement
exist
exist vascular disease
potency of the specific estrogen
numbness of a arm
hematologic concern
risk of endometrial cancer
change in appetite
family history of breast cancer
severity
migraine
long term use
adenocarcinoma of the cervix
history of previous thrombotic disease
severe pain
endometrial carcinoma
geographic tongue
oral contraceptive user
speech
accelerate growth
finding
nervous system
young diabetic woman
firm conclusion
deficiency of these component
preexist systemic disease
itch
focal nodular hyperplasia
estrogen component of this combination product
swell
significant blood pressure
complex alteration in plasma lipid profile
specific group of woman
enlargement
bias
relative amount
case of venous thrombosis
termination
discharge
lack of energy
be breakthrough bleeding
thrombotic stroke
long term use of oral contraceptive
shortness of breath
persistent headache
lower risk
hepatic hemangioma
rare case of retinal thrombosis
face
menstrual irregularity
case of chorea
amenorrhea
progestin
previous thrombotic disease
levonorgestrel
increase risk of dysplasia
decision
severe dizziness